Patent Assignment
Reel/Frame 065377/0580
Merger
Recorded: 2023-10-27
Pages: 16
Assignor
SUMITOMO PHARMA ONCOLOGY, INC.
Executed: 2023-09-15
Assignee
SUMITOMO PHARMA AMERICA, INC.
84 WATERFORD DRIVE, MARLBOROUGH, MASSACHUSETTS, 01752
Covered Properties
(3)
ALK5 Inhibitors for Treating Myelodysplastic Syndrome
Application:
16/740,219 →
Publication:
US 2020/0323851
ALK5 Inhibitors for Treating Myelodysplastic Syndrome
Application:
18/331,817 →
Publication:
US 2024/0075033
ALK5 Inhibitors for Treating Myelodysplastic Syndrome
Application:
62/790,961 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 24, 2019
From: BEARSS, DAVID J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 049842/0561 →
Assignment of Assignor's Interest
Jan 24, 2020
From: BEARSS, DAVID J.; WARNER, STEVEN L.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 051613/0030 →
Merger
Jul 10, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053172/0344 →
Change of Name
Jul 10, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053184/0663 →
Change of Name
Apr 25, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059787/0758 →